Clinical Trial Update: Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant Glioma [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update reporting the completion of a study evaluating thiotepa followed by peripheral stem cell or bone marrow transplantation …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Glioma

Drugs mentioned

• THIOTEPA (THIOTEPA)

Snippet

Sponsor: Herbert Irving Comprehensive Cancer Center | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: COMPLETED